David Sharon
Hematology & Oncology · West Long Branch, NJNPI 1730299041
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in NJ, where the typical reported total is $2,686.
Across 155 payments — averaging $12.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$335
- Genentech USA, Inc.$230
- Novartis$215
- Johnson & Johnson$197
- Seagen Inc.$123
- AstraZeneca$108
- plus $668 from 19 others
What the payments were for
- Food & beverage$1,86099%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 35 | $335 |
| Genentech USA, Inc. | 24 | $230 |
| Novartis | 17 | $215 |
| Johnson & Johnson | 14 | $197 |
| Seagen Inc. | 9 | $123 |
| AstraZeneca | 8 | $108 |
| Pfizer | 6 | $75 |
| Puma Biotechnology, Inc. | 4 | $75 |
| Eisai Inc. | 5 | $67 |
| Merck | 5 | $64 |
| Bayer | 3 | $48 |
| Lilly USA, LLC | 3 | $42 |
| AbbVie | 3 | $40 |
| Sanofi | 3 | $40 |
| Bristol Myers Squibb | 3 | $37 |
| Boehringer Ingelheim | 2 | $27 |
| Amgen | 2 | $26 |
| Astellas Pharma US Inc | 2 | $24 |
| Dendreon Pharmaceuticals LLC | 1 | $18 |
| Dova Pharmaceuticals | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Gilead | 1 | $14 |
| Exelixis Inc. | 1 | $13 |
How this compares
$1,874 in reported general payments places this provider in the 45th percentile of 362 hematology & oncology providers in New Jersey.
Other hematology & oncology in West Long Branch
- Robert SpiegelWestfield$864K
- Amit PatelJersey City$770K
- Joshua StraussSpringfield$739K
- Charles FarberMorristown$609K
- Michael ScolaMorristown$506K
- Eshan PatelSomerville$420K
- Arturo Loaiza-BonillaPennington$406K
- Ashish ShahSpringfield$394K
- Carl HenningsonManasquan$349K
- Anthony BottiLivingston$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.